They said it at DeviceTalks Boston

Proximie CEO Nadine Hachach-Haram [Photo courtesy of Proximie]Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead.

Here are some of the most quotable insights from panelists and speakers at our live event.

And make sure to save the date — and save your seat — for DeviceTalks West in Santa Clara, California on Oct. 19 and 20.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

They said it at DeviceTalks Boston

Proximie CEO Nadine Hachach-Haram [Photo courtesy of Proximie]

Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead.

Here are some of the most quotable insights from panelists and speakers at our live event.

And make sure to save the date — and save your seat — for DeviceTalks West in Santa Clara, California on Oct. 19 and 20.

Read on to hear what medtech leaders had to say at DeviceTalks Boston 2022.

Next >>

Read more
  • 0

Stryker opens new R&D facility in India

Stryker (NYSE:SYK) this week announced it opened a new research and development facility in India.

Dubbed Stryker’s Global Technology Center (SGTC), the 150,000 sq. ft facility will be based at the International Tech Park in Gurgaon and will help accelerate innovation in India.

“Innovation is in Stryker’s DNA. SGTC strengthens our ability to innovate and develop new products and solutions that help improve and save lives around the world. We are proud that Stryker positively impacts more than 100 million patients’ lives each year and the demand for our offerings is growing,” Stryker’s MedSurg and Neurotechnology Group President Andy Pierce said in a news release.

Stryker established its first research and development facility in India more than 15 years ago with the purpose to support R&D functions in domestic and other emerging markets. With more than 1,000 employees at its first facility, the new SGTC furthers Stryker’s commitment…

Read more
  • 0

Onkos Surgical to acquire Stryker’s Juvenile Tumour System

Onkos Surgical announced today that it agreed to acquire the Juvenile Tumour System (JTS) from Stryker (NYSE:SYK).

Parsippany, New Jersey-based Onkos entered into a definitive agreement with the orthopedic technology giant over the system designed to enable limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, severe trauma, revisions, oncology and malignant diseases.

Onkos, which specializes in solutions for musculoskeletal oncology and other complex orthopedic conditions, said in a news release that the JTS allows for the non-invasive lengthening of the implant post-surgery over time in a clinical setting.

The design of JTS eliminates the need for multiple lengthening surgeries, anesthesia or sedation, therefore helping to reduce the risk of complications and cost associated with limb reconstruction surgery.

“This is a significant day for Onkos Surgical and the musculoskeletal oncology community,…

Read more
  • 0

Stryker’s spine guidance software wins FDA clearance

[Image from Stryker]Stryker (NYSE:SYK) announced today that its Q Guidance System for advanced surgery planning received FDA 510(k) clearance.

Kalamazoo, Michigan-based Stryker designed the Q Guidance system for use with its spine guidance software for advanced planning and intraoperative guidance that enables open or percutaneous computer-assisted surgery.

Q Guidance offers multiple tracking options, sophisticated software algorithms and smart instrumentation with a high-performance navigation camera. Its redesigned software applications accompany semi-automatic and automatic segmentation features, gesture recognition and broad compatibility with various types of image sets.

When used with the Airo TruCT mobile CT scanner, Stryker’s digital guidance ecosystem delivers automatic image registration and also pairs high-performance tracking capabilities with cutting-edge intraoperative image quality and scan volume.

According to a news release, th…

Read more
  • 0

Stryker launches dynamic compression system for foot, ankle applications

[Image from Stryker]Stryker (NYSE:SYK) announced today that it launched its EasyFuse dynamic compression system for its ankle and foot portfolio.

Kalamazoo, Michigan-based Stryker designed its EasyFuse dynamic compression system to decrease surgical complexity, provide strong dynamic-compression implants and reduce waste in the operating room.

The company created the system using nitinol, a nickel titanium alloy metal known for strength and shape recovery, according to a news release. It has an extra-wide staple bridge designed to distribute forces and provide consistent strength, as well as universal, sterile packed instrumentation to decrease surgical complexity and reduce material waste in the OR.

EasyFuse’s intuitively designed inserter offers surgeons confidence in implant deployment while also facilitating quick and easy implant reloading if desired, Stryker said.

“The EasyFuse dynamic compression system is another key addition to Stryker…

Read more
  • 0

How Stryker includes users for product design in the digital age

“Focus on UI/UX (user interface and user experience) is paramount,” said Siddarth Satish, VP of Digital Innovation for the Surgical Technologies business at Stryker. [Photo courtesy of Stryker]Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial.

Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them.

The DeviceTalks Boston panel of Stryker executives was moderated by Stryker Orthopaedics and Spine Group President Spencer Stiles this week. Read our earlier coverage on their discussion of medtech trends and more from leaders at Medtronic and Harvard University.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more

  • 0

How Stryker includes users for product design in the digital age

“Focus on UI/UX (user interface and user experience) is paramount,” said Siddarth Satish, VP of Digital Innovation for the Surgical Technologies business at Stryker. [Photo courtesy of Stryker]

Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial.

Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them.

The DeviceTalks Boston panel of Stryker executives was moderated by Stryker Orthopaedics and Spine Group President Spencer Stiles this week. Read our earlier coverage on their discussion of medtech trends and more from leaders at Medtronic and Harvard University.

The following has been lightly edited for space and clarity.

Read more

  • 0

Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’

Tracy Robertson is VP of Digital at Stryker. [Photo courtesy of Stryker]The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech.

Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo, Michigan–based orthopedic device giant.

It was only the first question posed to the panel yesterday, which also featured Dave Lively — SVP of Product Management, Vocera (now part of Stryker) — and was moderated by Orthopaedics and Spine Group President Spencer Stiles.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’

The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech.

Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo, Michigan–based orthopedic device giant.

It was only the first question posed to the panel, which also featured Dave Lively — SVP of Product Management, Vocera (now part of Stryker) — and was moderated by Orthopaedics and Spine Group President Spencer Stiles. Watch for more from the discussion at Medical Design & Outsourcing.

The following has been lightly edited for space and clarity.

Tracy Robertson is VP of Digital at Stryker. [Photo courtesy of Stryker]

Tracy Robertson: “The one that I think a…
Read more
  • 0

How technology is changing the operating room

With all the hype around the use of data, artificial intelligence (AI) and other technologies, the operating room environment is ever-changing.

But, how does it translate to what clinicians do in practice and how will it improve?

On the “How technology is changing the OR” panel at DeviceTalks Boston, Proximie CEO Nadine Hachach-Haram posited that question, saying that the excitement around the technology must be met with the right application.

“The quality of care has improved access but how does it ultimately make sure every patient is getting the best care the first time, every time?” Hachach-Haram said. “With that in mind, value and impact was always front of mind. … We recognized that we needed to build something fit for now that fit for the future as well.”

Hachach-Haram was on the panel alongside Activ Surgical CEO Todd Usen, Stryker VP of Digital Innovation for Surgical Technologies Siddarth Satish …

Read more
  • 0

Stryker faced challenges in Q1 — but it still beat The Street

Stryker (NYSE:SYK) today reported first-quarter results that exceeded Wall Street expectations, even in what CEO Kevin Lobo described as a “challenging macroeconomic environment.”

“We are encouraged by the steady improvement of surgery volumes and the robust demand for our capital products; however, we expect supply chain challenges to persist for much of the year,” Lobo said in the earnings news release posted this evening.

The Kalamazoo, Michigan–based orthopedic device giant earned $323 million, or 84¢ per share, off $4.275 billion in sales for the quarter ended March 31, 2022. The results represented 7% bottom-line growth and 8% top-line growth compared with Q1 2021.

Adjusted to exclude one-time items, earnings per share were $1.97, two pennies ahead of The Street, where analysts were looking for $1.95 earnings per share and $4.18 billion in sales.

Stryker now expects full-year 2022 organic net sales growth towards the …

Read more
  • 0